Latika Dhawan
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Embryo Implantation | 8 | 2000 | 6 |
Why?
|
Chemokine CCL2 | 2 | 2007 | 57 |
Why?
|
Receptors, Glucocorticoid | 1 | 2007 | 26 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2007 | 59 |
Why?
|
RNA Stability | 1 | 2007 | 38 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2007 | 35 |
Why?
|
Macaca mulatta | 9 | 2000 | 71 |
Why?
|
Endometrium | 5 | 2000 | 27 |
Why?
|
Peptides | 2 | 2000 | 154 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2000 | 22 |
Why?
|
Blastocyst | 3 | 2000 | 10 |
Why?
|
Mifepristone | 2 | 2003 | 30 |
Why?
|
Interleukin-6 | 3 | 2002 | 145 |
Why?
|
Administration, Intravaginal | 5 | 2000 | 10 |
Why?
|
Pregnancy | 8 | 2000 | 455 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 47 |
Why?
|
Lymphokines | 2 | 2000 | 61 |
Why?
|
Protein Kinase C-delta | 1 | 2010 | 10 |
Why?
|
Animals | 11 | 2000 | 1031 |
Why?
|
Rats, Sprague-Dawley | 2 | 2007 | 257 |
Why?
|
Cell-Free System | 1 | 2007 | 34 |
Why?
|
Atherosclerosis | 1 | 2007 | 29 |
Why?
|
Hormone Antagonists | 1 | 2007 | 26 |
Why?
|
RNA, Messenger | 3 | 2000 | 394 |
Why?
|
Dexamethasone | 1 | 2007 | 109 |
Why?
|
Progesterone | 3 | 2000 | 42 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
|
Pregnancy Proteins | 2 | 2000 | 7 |
Why?
|
Angiogenesis Inhibitors | 2 | 2001 | 15 |
Why?
|
Contraceptives, Postcoital, Synthetic | 1 | 2003 | 1 |
Why?
|
Male | 9 | 2000 | 1553 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2000 | 8 |
Why?
|
Nitric Oxide | 1 | 2005 | 85 |
Why?
|
Inflammation | 1 | 2007 | 208 |
Why?
|
Rats | 2 | 2007 | 530 |
Why?
|
Interleukin-1 | 1 | 2003 | 109 |
Why?
|
Transforming Growth Factor beta | 2 | 2002 | 99 |
Why?
|
Growth Inhibitors | 1 | 2002 | 33 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 64 |
Why?
|
Tampons, Surgical | 1 | 2000 | 1 |
Why?
|
Anti-Infective Agents | 1 | 2001 | 54 |
Why?
|
Chorionic Gonadotropin | 1 | 2000 | 27 |
Why?
|
Proteins | 1 | 2003 | 192 |
Why?
|
Cells, Cultured | 1 | 2007 | 447 |
Why?
|
Embryo, Mammalian | 1 | 2000 | 99 |
Why?
|
Leukemia Inhibitory Factor | 3 | 2002 | 7 |
Why?
|
Immunohistochemistry | 4 | 2000 | 355 |
Why?
|
Female | 9 | 2000 | 1643 |
Why?
|
Cyclohexanes | 3 | 2000 | 15 |
Why?
|
Sesquiterpenes | 3 | 2000 | 24 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2000 | 94 |
Why?
|
Anti-Bacterial Agents | 1 | 2000 | 195 |
Why?
|
In Situ Hybridization | 2 | 2000 | 135 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 39 |
Why?
|
Microscopy, Electron | 2 | 2001 | 178 |
Why?
|
Epithelial Cells | 2 | 2001 | 135 |
Why?
|
Transcriptional Activation | 1 | 2010 | 99 |
Why?
|
Blotting, Western | 1 | 2010 | 275 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 243 |
Why?
|
Endothelium, Vascular | 2 | 2001 | 139 |
Why?
|
Dihydrolipoamide Dehydrogenase | 1 | 2005 | 1 |
Why?
|
Morula | 1 | 2005 | 1 |
Why?
|
Decidua | 1 | 2005 | 9 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2005 | 23 |
Why?
|
Guanidines | 1 | 2005 | 26 |
Why?
|
Epithelium | 1 | 2005 | 101 |
Why?
|
Gestational Age | 1 | 2005 | 114 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 44 |
Why?
|
Contraceptives, Oral | 1 | 2003 | 10 |
Why?
|
Menstrual Cycle | 1 | 2003 | 13 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 26 |
Why?
|
Gonadal Steroid Hormones | 1 | 2003 | 30 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 65 |
Why?
|
Molecular Chaperones | 1 | 2003 | 30 |
Why?
|
Humans | 1 | 2007 | 1856 |
Why?
|
Models, Animal | 1 | 2003 | 85 |
Why?
|
Glycoproteins | 1 | 2003 | 113 |
Why?
|
Placentation | 1 | 2000 | 3 |
Why?
|
Signal Transduction | 1 | 2010 | 313 |
Why?
|
Radioimmunoassay | 1 | 2000 | 81 |
Why?
|
Trophoblasts | 1 | 2000 | 13 |
Why?
|
Estradiol | 1 | 2001 | 78 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 431 |
Why?
|
